Loading patent…
AssigneeThe Johns Hopkins University
InventorsPaul M. Kim, Michael D. Kornberg, Peter A. Calabresi, Solomon H. Snyder
Estimating the term…
The disclosure provides methods for (i) treating multiple sclerosis in patient, (ii) treating a patient having symptoms of multiple sclerosis, (iii) preventing the onset of multiple sclerosis symptoms in patient having multiple sclerosis or predisposed to multiple sclerosis; (iv) promoting or enhancing immunomodulation and remyelination and/or myelin repair in a subject in need thereof; (v) a neuroinflammatory disorder; (vi) Amyotrophic Lateral Sclerosis; or (vii) a demyelinating disease or disorder or a hypomyelinating condition, each method comprising administering a therapeutically effective amount of a bryostatin compound to the patient.
A method for treating multiple sclerosis in patient, comprising administering a therapeutically effective amount of a bryostatin to the patient.
2-3. (canceled)
A method for treating a patient suffering from a neuroinflammatory disorder or disease, comprising administering a therapeutically effective amount of a bryostatin to the patient, or
(canceled)
(canceled)
(canceled)
17-21. (canceled)
23-37. (canceled)
(canceled)
A pharmaceutical kit comprising:
41-47. (canceled)
Dependencies are inferred from the claim text.